---
figid: PMC5872357__jcdd-05-00009-g001
figtitle: Epac signalosome in cardiac hypertrophy and ischemia
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5872357
filename: jcdd-05-00009-g001.jpg
figlink: /pmc/articles/PMC5872357/figure/jcdd-05-00009-f001/
number: F1
caption: Epac signalosome in cardiac hypertrophy and ischemia. Under adrenergic stimulation,
  the Epac1–β-arrestin complex is recruited at the β1-AR, and activates a pro-hypertrophic
  signaling pathway. Epac1 is also scaffolded at the nuclear envelope with phospholipase
  C (PLC)ε and muscle-specific A-kinase anchoring proteins (mAKAP) to regulate the
  hypertrophic gene program. In the nuclear/perinuclear region, PLCε increases nuclear
  Ca2+ content via the activation of the perinuclear IP3 receptor (IP3-R). Epac1 hypertrophic
  signaling also involves CaMKII-dependent phosphorylation of RyR2, leading to Ca2+
  leak from the sarcoplasmic reticulum and subsequent calcineurin (CaN) activation.
  The anti-hypertrophic action of the growth hormone-releasing hormone (GHRH) or its
  agonistic analog, MR-409, involves the protein kinase A (PKA)-dependent inhibition
  of Epac1 expression. MicroRNA-133 (miR-133) is cardioprotective, and targets several
  components of β1-AR signaling. In the context of cardiac ischemia, mitochondrial
  Epac1 (MitEpac1) is activated by cAMP produced by the soluble adenylyl cyclase (sAC),
  and increases Ca2+ overload and ROS accumulation to promote mitochondrial permeability
  transition pore (MPTP) opening and cardiomyocyte apoptosis. α-KG,α-ketoglutarate;
  β1-AR, β1-adrenergic receptor; AC, transmembrane adenylyl cyclase; CaMKIIδ, Ca2+/calmodulin-dependent
  protein kinase II δ-isoform; cAMP, cyclic adenosine monophosphate; DAG, diacylglycerol;
  GHRH-R, GHRH receptor; GRP75, chaperone glucose-regulated protein 75; HDAC4, histone
  deacetylase 4; IDH2, isocitrate dehydrogenase 2; IP3, inositol-1,4,5-trisphosphate;
  IP3R1, IP3 receptor 1; IP3R1, inositol-1,4,5-triphosphate receptor 1; MEF2, myocyte
  enhancer factor-2; NFAT, nuclear factor of activated T-cells; PIP2, phosphatidylinositol
  4,5-biphosphate; ROS, reactive oxygen species; Ser, serine; TCA, tricarboxylic acid
  cycle; VDAC1, voltage-dependent anion channel 1.
papertitle: Epac Function and cAMP Scaffolds in the Heart and Lung.
reftext: Marion Laudette, et al. J Cardiovasc Dev Dis. 2018 Mar;5(1):9.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9684489
figid_alias: PMC5872357__F1
figtype: Figure
redirect_from: /figures/PMC5872357__F1
ndex: 45172260-decc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5872357__jcdd-05-00009-g001.html
  '@type': Dataset
  description: Epac signalosome in cardiac hypertrophy and ischemia. Under adrenergic
    stimulation, the Epac1–β-arrestin complex is recruited at the β1-AR, and activates
    a pro-hypertrophic signaling pathway. Epac1 is also scaffolded at the nuclear
    envelope with phospholipase C (PLC)ε and muscle-specific A-kinase anchoring proteins
    (mAKAP) to regulate the hypertrophic gene program. In the nuclear/perinuclear
    region, PLCε increases nuclear Ca2+ content via the activation of the perinuclear
    IP3 receptor (IP3-R). Epac1 hypertrophic signaling also involves CaMKII-dependent
    phosphorylation of RyR2, leading to Ca2+ leak from the sarcoplasmic reticulum
    and subsequent calcineurin (CaN) activation. The anti-hypertrophic action of the
    growth hormone-releasing hormone (GHRH) or its agonistic analog, MR-409, involves
    the protein kinase A (PKA)-dependent inhibition of Epac1 expression. MicroRNA-133
    (miR-133) is cardioprotective, and targets several components of β1-AR signaling.
    In the context of cardiac ischemia, mitochondrial Epac1 (MitEpac1) is activated
    by cAMP produced by the soluble adenylyl cyclase (sAC), and increases Ca2+ overload
    and ROS accumulation to promote mitochondrial permeability transition pore (MPTP)
    opening and cardiomyocyte apoptosis. α-KG,α-ketoglutarate; β1-AR, β1-adrenergic
    receptor; AC, transmembrane adenylyl cyclase; CaMKIIδ, Ca2+/calmodulin-dependent
    protein kinase II δ-isoform; cAMP, cyclic adenosine monophosphate; DAG, diacylglycerol;
    GHRH-R, GHRH receptor; GRP75, chaperone glucose-regulated protein 75; HDAC4, histone
    deacetylase 4; IDH2, isocitrate dehydrogenase 2; IP3, inositol-1,4,5-trisphosphate;
    IP3R1, IP3 receptor 1; IP3R1, inositol-1,4,5-triphosphate receptor 1; MEF2, myocyte
    enhancer factor-2; NFAT, nuclear factor of activated T-cells; PIP2, phosphatidylinositol
    4,5-biphosphate; ROS, reactive oxygen species; Ser, serine; TCA, tricarboxylic
    acid cycle; VDAC1, voltage-dependent anion channel 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ac
  - Arr2
  - Rap2l
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - mir-133
  - CaMKII
  - Itpr
  - sac
  - moa
  - HDAC4
  - NFAT
  - Mef2
  - ca
  - GHRH
  - GHRHR
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - RAPGEF3
  - RAP2A
  - PLCL1
  - PLCE1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CAMK2G
  - ITPR1
  - ITPR3
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - AKAP6
  - IDH2
  - RYR2
  - HSPA9
  - MEF2A
  - MYEF2
  - MEF2C
  - MEF2D
  - MEF2B
  - Adrenaline
  - Noradrenaline
  - SAC
  - CaN
  - Isocitrate
  - TCA
  - Ser
  - MPTP
  - PRO-APOPTOTIC
  - PRO
  - Ischemia
  - Hypertrophic
---
